Conclusions: Individual differences among patients affect the likelihood they will complete a particular treatment, and clinicians can consider these moderators in treatment planning. In the future, treatment selection models could be used to increase the percentage of patients who will receive a full course of treatment, but replication and extension of such models, and consideration of how best to integrate them into routine practice, are needed.
of patients with treatments would result in lower attrition rates (Zilcha-Mano et al., 2016) . For example, some clinicians are concerned that patients with past childhood abuse are more likely to drop out of exposure-focused therapies, due to concerns about symptom worsening (van Minnen, Hendriks, & Olff, 2010) . However, temporary symptom exacerbation is both relatively uncommon (Foa, Zoellner, Feeny, Hembree, & Alvarez-Conrad, 2002; Larsen, Wiltsey Stirman, Smith, & Resick, 2016) , and has not been found to predict dropout in these treatments (Kehle-Forbes et al., 2016; Larsen et al., 2016) .
Indeed, there have only been a few tests of this or any other theories concerning patient characteristics that might predict greater retention in one treatment relative to another, comparing patients with different characteristics (Cloitre, 2015) . In one study comparing interpersonal psychotherapy (IPT) to prolonged exposure (PE) for PTSD, patients with comorbid depression exhibited a higher dropout rate in PE, relative to IPT, whereas this was not the case for patients without comorbid depression . In another, patients with higher levels of anger were more likely to drop out of PE than cognitive processing therapy (CPT) (Rizvi, Vogt, & Resick, 2009 ).
Importantly, no investigation of patient characteristics and differential dropout in PTSD has included a test of whether and how a set of factors may combine to predict differential retention or engagement.
Whereas, in principle, single patient-level moderators of dropout could inform clinically meaningful recommendations for treatment selection, if there exist multiple moderators, and they are not strongly correlated with one another, a patient could have a mix of characteristics that both recommend them for or against a particular treatment .
To address this clinically relevant knowledge gap (Cloitre, 2015) and to illustrate methodologies of treatment selection that may ultimately result in better patient engagement and outcomes (DeRubeis et al., 2014; Wallace, Frank, & Kraemer, 2013; Zilcha-Mano et al., 2016) , we conducted a comprehensive moderator analysis from a clinical trial comparing CPT (Resick & Schnicke, 1993) and PE (Foa, Hembree, & Rothbaum, 2007) in a sample of women with PTSD who were survivors of rape (Resick, Nishith, Weaver, Astin, & Feuer, 2002) , to assess comparative risk of dropout between treatments. Given that CPT and PE are efficacious treatments for PTSD, clinical tools that could be used to maximize a patient's likelihood of completing treatment should prove to be valuable to patients as well as to care systems.
METHODS

Patients
Patients were women who qualified for a DSM-IV diagnosis of PTSD through a standardized, reliable, and masked trauma interview (Resick, Jordan, Girelli, Hutter, & Marhoefer-Dvorak, 1988) . Patients were included if they had experienced a completed rape in childhood or adulthood, they were at least 3 months posttrauma, and, if on medication, they reported that they were stabilized on a current dose (n = 48; 30.1%) by client self-report. 1 At least one other major trauma victimization, apart from the index rape, was reported by 86% of those in the sample (mean = 6.4, SD = 4.9). On average, 1.4 of those other trauma victimizations were classified as sexual in nature and 5.0 were nonsexual (e.g., physical assault). Exclusion criteria included current psychosis, substance dependence, illiteracy, instability of psychiatric medication dosages, and acute risk of harm to one's self or others.
Participants were randomized to PE, CPT, or a waitlist for 6 weeks.
Following the wait, the delayed treatment participants were randomly assigned to either CPT or PE. Further details on trial methodology and patient sample can be found in the primary outcome publication (Resick et al., 2002) .
Treatments
Cognitive processing therapy
CPT is a primarily cognitive therapy. The treatment is delivered over 12 sessions for 50-60 min each and, for the sample used in the current study, it followed the original manual as written by Resick and Schnicke (1993) . CPT includes psychoeducation, an impact statement, training in identifying thoughts and emotions, two assigned written accounts of the traumatic event that are reviewed in the subsequent session and then read daily between sessions, and cognitive restructuring with regard to beliefs about the meaning of the event and the implications of the trauma for one's life. The second half of the treatment focuses on disruptions in beliefs about safety, trust, power/control, esteem, and intimacy, which may have resulted from the traumatic exposure.
Prolonged exposure
PE is based upon emotional processing theory, which suggests that PTSD symptomatology is maintained primarily by avoidance of trauma cues, and by negative cognitions about the self, the world, and one's reaction to the trauma. The nine-session PE protocol includes four components: education and explanation of rationale for PE, breathing retraining, behavioral exposures, and imaginal exposures (Foa et al., 2007) . The majority of the sessions (sessions 3-9) involve imaginal exposure of the traumatic event for 45-60 min of the 90-min session.
Measures
Twenty potential moderator variables were selected for this exploratory analysis, representing participant demographics, interpersonal and crime history, PTSD symptomatology, comorbid symptomatology (e.g., depression symptoms), and cognitive-personality features of the patient (e.g., trauma cognitions). Counting subscores of measures, there were over 50 baseline variables we could have potentially chosen. We decided to limit ourselves to 20 variables to balance (Ammons & Ammons, 1962) Years since index rape
Interpersonal history
Assessing Environments-III, Physical Punishment Scale-Severity of Childhood Physical Abuse (Rowan, Foy, Rodriguez, & Ryan, 1994) Sexual Abuse Exposure Questionnaire-Severity of Childhood Sexual Abuse (Rowan et al., 1994) Conflict Tactics Scale-Abuse by Current Partner (Straus, Hamby, Boney-McCoy, & Sugarman, 1996) Total sex crime exposures
Psychiatric symptoms
Clinician-Administered PTSD Scale Total Score (Blake et al., 1995) Posttraumatic Symptom Scale (PSS) (Foa, Riggs, Dancu, & Rothbaum, 1993 )-Avoidant symptoms PSS-Arousal symptoms PSS-Re-experiencing symptoms BDI-II Depression (Steer, Ball, Ranieri, & Beck, 1999) Dissociative Experiences Scale (Carlson & Putnam, 1993) 
Cognitive features
Beck Hopelessness Scale (Beck, Weissman, Lester, & Trexler, 1974) State-Trait Anger Expression Inventory (Trait) (Spielberger, Sydeman, Owen, & Marsh, 1999) Trauma-Related Guilt Inventory (TRGI)-Total Trauma Cognitions (Kubany et al., 1996) this trial dataset; Rizvi et al., 2009) , and race (Lester, Artz, Resick, & Yinong, 2010) have been identified in previous PTSD trials as being relevant for predicting dropout rates in trauma-focused treatments.
Finally, many of the variables were chosen because they are relatively easy to collect in practice (e.g., age; time since index trauma) or are routinely collected in the process of diagnosing PTSD (e.g., elevations
in particular PTSD symptom clusters), because an eventual goal would be to deploy treatment selection strategies in clinical practice Selected variables are described in Table 1 . All observer-based measures were obtained by trained study personnel who were masked to treatment condition, and inter-rater reliability was established for all measures (Resick et al., 2002) .
Because 11 patients dropped out during the waiting list period, prior to being informed of their assignment to treatment, their data could not inform a model of differential dropout, leaving 160 patients from the intention-to-treat sample who were informed of their treatment randomization. 3
Analyses
Missing baseline data
Missing values ranged from 0 to 11 (trauma cognitions), with the median level of missingness among measures with missing values being 3. Explorations of missing data patterns relationships between degree of missingness and the criterion of treatment dropout. Therefore, a single-dataset random forest imputation strategy was undertaken (Stekhoven & Bühlmann, 2012) , using all available pretreatment and outcome data.
Variable selection
All analyses were conducted in the R statistical computing language.
Initial moderator variable selection was performed using a bootstrapped, random forest variant of model-based recursive partitioning (MoB) (Garge, Bobashev, & Eggleston, 2013) . MoB takes a basic parametric model, and attempts to detect variables along which splits into two subgroups lead to significantly different model behavior on either side of the split. It has been applied previously in moderator investigations in psychiatry (Driessen et al., 2016; Zilcha-Mano et al., 2016) .
The extension of this model employs MoB within bootstrapped resamplings of the dataset. For each bootstrap, the resulting tree is tested on the out-of-bag sample, which is held out of a given tree construction. A variable's ability to predict out of bag is compared to the ability of randomly permuted data to make the same prediction. Variables with a prediction statistic higher than that of the absolute value of the moderator with the most negative predictive value (i.e., in which the permuted data are superior to the real data) are retained (Strobl, Boulesteix, Kneib, Augustin, & Zeileis, 2008) . Twenty thousand bootstrapped replicates were run (minimum 10 patients at P < .10 per split; random 10 variables per node).
The variables that emerged from the MoB procedure were placed into a bootstrapped variant of an Akaike information criterion-based backward selection model (Austin & Tu, 2004) . Terms representing interactions with treatment condition ("prescriptive" variables) as well as terms representing main effects of individual variables that predicted dropout regardless of condition ("prognostic" variables) that were retained in at least 60% of the bootstrapped replicates (k = 20,000) were included in the final model, per Austin and Tu's (2004) recommendations. Combined, the two-step bootstrap filtering partially protects against overfitting by ensuring that any given variable is predictive across bootstrapped replications of the data structure, and predicts significantly better than the noise of the dataset itself (i.e., via permutation test) Davidson & Hinkley, 1997; Koutsouleris et al., 2016) . Any variable that survived the two-step variable selection process was included in the final model.
Treatment selection model
Logistic regression models predicting treatment completion were used to ascertain the statistical significance of each of the selected moderator variables individually, when each was included in a model that also contained treatment condition and the interaction. An omnibus logistic model was also fit in which all moderator variables, and their interactions with treatment, were simultaneously included.
To estimate the degree to which assigning patients to a specific treatment on the basis of the outputs of the logistic model would yield superior treatment completion rates, the Personalized Advantage Index (PAI) approach was implemented. In this approach, multiple predictors and moderators are combined in a statistical model that is then used to predict for each patient, which treatment they would be more likely to complete. An index that reflects the magnitude of the predicted advantage is also given by the method (DeRubeis et al., 2014) . A stratified fivefold cross-validation scheme was used to estimate the predictive value of the final logistic model indicated by the variable selection process (Kohavi, 1995) . For any given patient, estimates of the probability of treatment completion for each treatment
were output from a model that used data from the fourfolds of the fivefold model in which their data were not included. The difference between the two model-predicted probabilities of completing each treatment was calculated, resulting in a signed (positive or negative)
score, indicating which of the treatments was determined to be "optimal" for that patient (i.e., the treatment in which they were predicted to be less likely to drop out).
To test the validity and potential utility of the set of predictions, logistic regressions were performed to compare the rates of treatment completion between patients who had been randomized to the treatment predicted by the PAI model to be their "optimal" treatment in terms of retention, as compared with patients randomized to the treatment predicted to be their "nonoptimal" treatment. Following DeRubeis et al. (2014), and on the understanding that PAI values close to zero are weak indicators of the relative advantage of one treatment over another, we also compared the optimal versus nonoptimal dropout rates in the subset of patients whose PAIs were among the highest 60% in absolute value.
RESULTS
Dropout rates
The average baseline data for PE and CPT patients can be found in Table 2 . There were no significant between conditions in baseline values for any moderator variables.
Of 30.6% of patients dropped out of the trial after randomization to one of the active treatment conditions, including those who did not attend any sessions (30.9% in PE; 30.4% in CPT; P = .947). Of patients in the minimal attention condition, 23.4% dropped out prior to being re-randomized to an active treatment condition. Their data were not used in these analyses. AE-III = Assessing Experiences III; BDI-II = Beck Depression Inventory; BHS = Beck Hopelessness Scale; CAPS = Clinician-Administered PTSD Scale; CTS = Conflict-Tactics Scale; DES = Dissociative Experiences Scale; PSS = Posttraumatic Symptom Scale; STAXI = State-Trait Anger Expression Inventory; TRGI = Trauma-Related Guilt Inventory. * P < .10.
Variable selection for dropout model
Final treatment selection model
In the combined model that included the all moderator variables interacting with treatment, their main effects, and the prognostic variables, two moderator variables remained statistically significant: intimate partner abuse, and race.
Patients were more likely to complete CPT, relative to PE, the higher their scores on the measure of current relationship abuse (log odds = −1.08 [95% CI: −2.20 to −0.13], SE = 0.52, P = .037) (see Fig. 1 ).
Within CPT, higher scores on the relationship abuse measure were not 
Dropout PAI
For each patient, the one model that did not include that patient's data (of the five cross-validation prediction models) was used to generate the predictions of that patient's likelihood of dropping out in each treatment. The signed difference between the two predictions 
DISCUSSION
In contrast to previous studies in which the relationship between individual patient characteristics and dropout have been examined separately, this study employed a novel methodology to identify each individual study participant's optimal treatment, based on their values on a set of characteristics. Employing machine-learning and bootstrapping methodologies, we detected several robust moderators of dropout between PE and CPTs, two first-line treatments for PTSD. In the context of a randomized controlled trial of PE and CPT for patients with rape-related PTSD, dropout rates were nearly identical. However, when we constructed and applied a cross-validated multivariable moderation model, it yielded predictions that distinguished which of the two treatments a given patient was most likely to complete, at a level well above chance. These findings suggest that the application of such modeling approaches may, in the future, be used successfully to identify an optimal treatment for each patient and thus decrease the likelihood that patients will terminate treatment before they are able to derive benefit.
Four moderators of dropout between CPT and PE were detected in this study, each of which was statistically significant when considered on its own, and two of which were significant in an omnibus model with all moderators included (race and relationship abuse as measured by the CTS). Although the nature of a moderator can suggest particular mechanisms for differential treatment tolerance, we cannot be certain from these data alone why these moderators had their observed influences. For example, both childhood physical abuse and current relationship abuse predicted dropout more in PE as compared to CPT.
A common mechanism for these two variables driving dropout in PE could be that memories of past or ongoing trauma may become activated, perhaps especially during imaginal exposures for the index rape.
These patients may find that it is difficult to tolerate exposure exercises (cf. Cloitre et al., 2010) or individuals with these experiences may be more likely to continue to avoid in an effort to cope with distressing memories and feelings. The moderating role of race to predict PE dropout could be due to any number of factors (Cloitre, 2015) , including that cultural differences may influence the perceived credibility of exposure-focused treatments or of their delivery by exclusively (in this trial) Caucasian clinicians. It also may be that minority stress or the covariation of race with other sociodemographic variables accounted for this relationship. As relatively little systematic research exists on why patients drop out of trauma-focused treatments for PTSD, or how these reasons can be addressed, our findings may point toward fruitful avenues for such research.
The ability to match patients with treatments that may be optimal in terms of engagement may reduce therapist concerns about potentially poor fits of evidence-based treatments for PTSD, as well as concerns that patients may not be able to tolerate certain treatments (OseiBonsu et al., 2017; Zubkoff, Carpenter-Song, Shiner, Ronconi, & Watts, 2016) . If these findings are replicated in future studies, the potential reach and effectiveness of trauma-focused PTSD treatments could be significantly increased. Such models could inform decision-support tools, similar to those used in other areas of medicine (Goldstein et al., 2002) , that would augment clinical decision making, and could be used in conjunction with other efforts to increase patient-centered, shared decisions about appropriate PTSD treatments (Mott, Stanley, Street, Grady, & Teng, 2014) .
Limitations
Several limitations concerning the sample and methodology of this study must be recognized. Sexual assault is an especially common primary trauma among PTSD patients (Breslau et al., 1998) , but it is not clear whether patterns observed in this population will generalize to other primary trauma populations, such as combat-related PTSD.
Although many variables relevant to PTSD were included in this study, several potentially important ones were not, including biological markers and patient preference (Feeny, Zoellner, Mavissakalian, & Roy-Byrne, 2009 ). Inclusion of a broader range of predictors would be expected to enhance the ability of a model to make these predictions, although the use of self-reported measures may make deployment of treatment selection in routine clinical practice more feasible.
In particular, all selected variables predicted more dropout in PE rather than CPT, which may indicate that we did not include variables important for predicting dropout in CPT specifically. Notably, three of the four selected variables (all but anger) had skewed distributions in our sample-such that the modal patient was not African American, was not exposed to childhood physical abuse, and was not experiencing current relationship abuse. This may have led to the unbalanced rate of PAI recommendations suggesting PE over CPT, reflecting an excess of small PE predictions near the indifference point who did not evidence any benefit from receiving their optimal treatment (see Fig. 3 , bottom 40% PAI).
It should also be noted that some of the patients classified as dropouts in this study may have benefitted from their treatment before they dropped out (Szafranski, Smith, Gros, & Resick, 2017) .
If such patients were counted as completers rather than dropouts, a somewhat different pattern of findings might have emerged (Szafranski et al., 2017) .
The selection of moderator variables was implemented in the same data-set as model estimations, which could lead to model overfitting and inflated relationships (Fiedler, 2011) . However, unlike nearly all moderator investigations in the psychiatric literature, we used a two-step bootstrapped variable selection process incorporating outof-bag predictions and permutation tests to select variables that are more likely to generalize to a different sample. Moreover, to limit bias in the model coefficients, we estimated the predictive ability of our selected variables using a fivefold cross-validation. When proper statistical controls are applied, even complex clinical interactions can replicate Koutsouleris et al., 2016; LorenzoLuaces et al., 2017 (Hastie, Tibshirani, & Friedman, 2009) . At this time, there are no other data from trials comparing CPT and PE for sexual trauma PTSD on which the present model could be tested. However, a large-scale trial comparing CPT and PE for PTSD among veterans (n = 900) is currently underway, which may provide a powerful opportunity to refine, reconstruct, and test the present treatment selection model (Schnurr et al., 2015) .
Finally, this study investigated only two of the commonly used and disseminated treatments for PTSD. More recent advances in CPT include making the written account of the trauma an optional element of CPT (Resick, Monson, & Chard, 2017) , although in routine practice, many clinicians received training, and are likely implementing, the version of CPT that includes the written account (Chard, Ricksecker, Healy, Karlin, & Resick, 2012) . One study suggests that dropout may be lower when the account is not included (Resick et al., 2008) . Thus, future research should include adequately powered investigation of methods to match patients to treatments that include explicit recounting of traumatic events versus those that do not.
Future directions
The present findings suggest that patient characteristics measured prior to treatment may be leveraged to make clinically useful predictions as to which PTSD treatment a patient is most likely to tolerate and complete, even though most such treatments have similar retention rates on average (Imel et al., 2013) . Although the generalizability of the moderators we identified should be explored in future trials, these moderators may nevertheless provide preliminary guidance for clinicians when planning to conduct a more exposure-focused (i.e., PE) versus cognitively focused (i.e., CPT) treatment with rape trauma PTSD patients. Understanding the individual risk factors for dropout unique to a treatment approach-for example, past or ongoing trauma for PEmight also alert clinicians to address proactively the potential reasons for dropout deriving from those risk factors, such as adding affective regulation/interpersonal skills training if a patient is too activated by exposures (Cloitre et al., 2010) .
If patients are strongly dissatisfied with or genuinely dissuaded by an initial treatment, they may be demoralized and less likely to attempt another treatment (Markowitz & Milrod, 2015) . On the other hand, studies with patients who engaged in and completed trauma-focused treatments indicate that they perceive them to be "worth it in the end" (Hundt, Barrera, Arney, & Stanley, 2017 (Caliendo & Kopeining, 2008) .
Overall, further research on moderators of dropout in PTSD will foster the further development of advanced treatment selection models that promise to enhance the clinical impact of already available evidence-based treatments for PTSD in routine clinical practice. 
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